Dawnrays Pharmaceutical (Holdings) Ltd - ESG Rating & Company Profile powered by AI
Other companies in the scoring industry group for Dawnrays Pharmaceutical (Holdings) Ltd are displayed. The Disclosure rating covers 17 UN SDGs including: 'Good Health & Wellbeing', 'Decent Work & Economic Growth' and 'Peace, Justice & Strong Institutions'. The assessment of Dawnrays Pharmaceutical (Holdings) Ltd was assembled by All Street Sevva using proprietary machine learning.
Dawnrays Pharmaceutical (Holdings) Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.3; made up of an environmental score of 6.0, social score of 8.0 and governance score of 8.0.
7.3
High ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
160 | YungShin Global Holding Corp | 7.5 | High |
160 | Zentiva SA | 7.5 | High |
191 | Dawnrays Pharmaceutical (Holdings) Ltd | 7.3 | High |
191 | Cellectis SA | 7.3 | High |
191 | Aurinia Pharmaceuticals Inc | 7.3 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Dawnrays Pharmaceutical (Holdings) Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Dawnrays Pharmaceutical (Holdings) Ltd disclose current and historical energy intensity?
Does Dawnrays Pharmaceutical (Holdings) Ltd report the average age of the workforce?
Does Dawnrays Pharmaceutical (Holdings) Ltd reference operational or capital allocation in relation to climate change?
Does Dawnrays Pharmaceutical (Holdings) Ltd disclose its ethnicity pay gap?
Does Dawnrays Pharmaceutical (Holdings) Ltd disclose cybersecurity risks?
Does Dawnrays Pharmaceutical (Holdings) Ltd offer flexible work?
Does Dawnrays Pharmaceutical (Holdings) Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Dawnrays Pharmaceutical (Holdings) Ltd disclose the number of employees in R&D functions?
Does Dawnrays Pharmaceutical (Holdings) Ltd conduct supply chain audits?
Does Dawnrays Pharmaceutical (Holdings) Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Dawnrays Pharmaceutical (Holdings) Ltd conduct 360 degree staff reviews?
Does Dawnrays Pharmaceutical (Holdings) Ltd disclose the individual responsible for D&I?
Does Dawnrays Pharmaceutical (Holdings) Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Dawnrays Pharmaceutical (Holdings) Ltd disclose current and / or historical scope 2 emissions?
Does Dawnrays Pharmaceutical (Holdings) Ltd disclose water use targets?
Does Dawnrays Pharmaceutical (Holdings) Ltd have careers partnerships with academic institutions?
Did Dawnrays Pharmaceutical (Holdings) Ltd have a product recall in the last two years?
Does Dawnrays Pharmaceutical (Holdings) Ltd disclose incidents of discrimination?
Does Dawnrays Pharmaceutical (Holdings) Ltd allow for Work Councils/Collective Agreements to be formed?
Has Dawnrays Pharmaceutical (Holdings) Ltd issued a profit warning in the past 24 months?
Does Dawnrays Pharmaceutical (Holdings) Ltd disclose parental leave metrics?
Does Dawnrays Pharmaceutical (Holdings) Ltd disclose climate scenario or pathway analysis?
Does Dawnrays Pharmaceutical (Holdings) Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Dawnrays Pharmaceutical (Holdings) Ltd disclose the pay ratio of women to men?
Does Dawnrays Pharmaceutical (Holdings) Ltd support suppliers with sustainability related research and development?
Does Dawnrays Pharmaceutical (Holdings) Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Dawnrays Pharmaceutical (Holdings) Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Dawnrays Pharmaceutical (Holdings) Ltd involved in embryonic stem cell research?
Does Dawnrays Pharmaceutical (Holdings) Ltd disclose GHG and Air Emissions intensity?
Does Dawnrays Pharmaceutical (Holdings) Ltd disclose its waste policy?
Does Dawnrays Pharmaceutical (Holdings) Ltd report according to TCFD requirements?
Does Dawnrays Pharmaceutical (Holdings) Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Dawnrays Pharmaceutical (Holdings) Ltd disclose energy use targets?
Does Dawnrays Pharmaceutical (Holdings) Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Dawnrays Pharmaceutical (Holdings) Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Dawnrays Pharmaceutical (Holdings) Ltd
These potential risks are based on the size, segment and geographies of the company.
Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, and oral antibiotics. It also provides and system specific medicines comprising cardiovascular systems; anti-allergic, anti-HBV, and digestive systems; urinary systems; and anti-pyretic analgesic, respiratory, and endocrine system drugs in the form of tablets, capsules, and granules. The company was founded in 1995 and is headquartered in Wan Chai, Hong Kong. Dawnrays Pharmaceutical (Holdings) Limited is a subsidiary of Fortune United Group Limited.